Literature DB >> 27305065

Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts.

François Guérard1,2, Yong-Sok Lee3, Kwamena Baidoo4, Jean-François Gestin5, Martin W Brechbiel4.   

Abstract

Aryliodonium salts have become precursors of choice for the synthesis of (18) F-labeled tracers for nuclear imaging. However, little is known on the reactivity of these compounds with heavy halides, that is, radioiodide and astatide, at the radiotracer scale. In the first comparative study of radiohalogenation of aryliodonium salts with (125) I(-) and (211) At(-) , initial experiments on a model compound highlight the higher reactivity of astatide compared to iodide, which could not be anticipated from the trends previously observed within the halogen series. Kinetic studies indicate a significant difference in activation energy (Ea =23.5 and 17.1 kcal mol(-1) with (125) I(-) and (211) At(-) , respectively). Quantum chemical calculations suggest that astatination occurs via the monomeric form of an iodonium complex whereas iodination occurs via a heterodimeric iodonium intermediate. The good to excellent regioselectivity of halogenation and high yields achieved with diversely substituted aryliodonium salts indicate that this class of compounds is a promising alternative to the stannane chemistry currently used for heavy radiohalogen labeling of tracers in nuclear medicine.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  astatine; halogenation; iodonium salts; nucleophilic substitution; radiopharmaceuticals

Year:  2016        PMID: 27305065      PMCID: PMC5013196          DOI: 10.1002/chem.201600922

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  31 in total

1.  Contribution of translational and rotational motions to molecular association in aqueous solution.

Authors:  Y B Yu; P L Privalov; R S Hodges
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

2.  Selective syntheses of no-carrier-added 2- and 3-[18F]fluorohalopyridines through the radiofluorination of halopyridinyl(4'-methoxyphenyl)iodonium tosylates.

Authors:  Joong-Hyun Chun; Victor W Pike
Journal:  Chem Commun (Camb)       Date:  2012-08-30       Impact factor: 6.222

3.  An alternative to the Sandmeyer approach to aryl iodides.

Authors:  Bao Hu; William H Miller; Kiel D Neumann; Ethan J Linstad; Stephen G DiMagno
Journal:  Chemistry       Date:  2015-03-10       Impact factor: 5.236

4.  Facile aromatic radiofluorination of [18F]flumazenil from diaryliodonium salts with evaluation of their stability and selectivity.

Authors:  Byung Seok Moon; Hee Seup Kil; Jun Hyung Park; Ji Sun Kim; Jimin Park; Dae Yoon Chi; Byung Chul Lee; Sang Eun Kim
Journal:  Org Biomol Chem       Date:  2011-11-07       Impact factor: 3.876

5.  Regiospecific reductive elimination from diaryliodonium salts.

Authors:  Bijia Wang; Joseph W Graskemper; Linlin Qin; Stephen G DiMagno
Journal:  Angew Chem Int Ed Engl       Date:  2010-06-01       Impact factor: 15.336

6.  Syntheses of mGluR5 PET radioligands through the radiofluorination of diaryliodonium tosylates.

Authors:  Sanjay Telu; Joong-Hyun Chun; Fabrice G Siméon; Shuiyu Lu; Victor W Pike
Journal:  Org Biomol Chem       Date:  2011-08-16       Impact factor: 3.876

7.  Conformational structure and energetics of 2-methylphenyl(2'-methoxyphenyl)iodonium chloride: evidence for solution clusters.

Authors:  Yong-Sok Lee; Milan Hodoscek; Joong-Hyun Chun; Victor W Pike
Journal:  Chemistry       Date:  2010-09-10       Impact factor: 5.236

Review 8.  Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy.

Authors:  François Guérard; Jean-François Gestin; Martin W Brechbiel
Journal:  Cancer Biother Radiopharm       Date:  2012-10-17       Impact factor: 3.099

9.  Diaryliodonium salts: a journey from obscurity to fame.

Authors:  Eleanor A Merritt; Berit Olofsson
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

10.  Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.

Authors:  Emma Aneheim; Anna Gustafsson; Per Albertsson; Tom Bäck; Holger Jensen; Stig Palm; Sofia Svedhem; Sture Lindegren
Journal:  Bioconjug Chem       Date:  2016-01-29       Impact factor: 4.774

View more
  6 in total

1.  Crystal Structures of Diaryliodonium Fluorides and Their Implications for Fluorination Mechanisms.

Authors:  Yong-Sok Lee; Joong-Hyun Chun; Milan Hodošček; Victor W Pike
Journal:  Chemistry       Date:  2017-03-02       Impact factor: 5.236

2.  Rapid Cu-Catalyzed [211At]Astatination and [125I]Iodination of Boronic Esters at Room Temperature.

Authors:  Sean W Reilly; Mehran Makvandi; Kuiying Xu; Robert H Mach
Journal:  Org Lett       Date:  2018-03-21       Impact factor: 6.005

3.  Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors.

Authors:  Dong Zhou; Sung Hoon Kim; Wenhua Chu; Thomas Voller; John A Katzenellenbogen
Journal:  J Labelled Comp Radiopharm       Date:  2017-06-14       Impact factor: 1.921

Review 4.  Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".

Authors:  Romain Eychenne; Michel Chérel; Férid Haddad; François Guérard; Jean-François Gestin
Journal:  Pharmaceutics       Date:  2021-06-18       Impact factor: 6.321

5.  Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies.

Authors:  F Guérard; L Navarro; Y-S Lee; A Roumesy; C Alliot; M Chérel; M W Brechbiel; J-F Gestin
Journal:  Bioorg Med Chem       Date:  2017-09-19       Impact factor: 3.641

6.  Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies.

Authors:  Marion Berdal; Sébastien Gouard; Romain Eychenne; Séverine Marionneau-Lambot; Mikaël Croyal; Alain Faivre-Chauvet; Michel Chérel; Joëlle Gaschet; Jean-François Gestin; François Guérard
Journal:  Chem Sci       Date:  2020-11-23       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.